Investigation of Epstein-Barr virus in breast carcinomas in Tunisia

Pathology Research and Practice

Volumn 207, Issue 11, 2011, Pages 695-700

  Hachana, Mohamed ^a   Amara, Khaled ^a   Ziadi, Sonia ^a   Romdhane, Essia ^a   Gacem, Riadh Ben ^a   Trimeche, Mounir ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Breast cancer; Epstein Barr virus; Tunisia

Indexed keywords

ESTROGEN RECEPTOR; LATENT MEMBRANE PROTEIN 1; VIRUS DNA;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; TUNISIA; VIRUS DETECTION;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; TUNISIA; VIRAL MATRIX PROTEINS;

EID: 82755177886     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.09.007     Document Type: Article

References (39)

1. Arbach H., Viglasky V., Lefeu F., Guinebretiere J.M., Ramirez V., Bride N., Boualaga N., Bauchet T., Peyrat J.P., Mathieu M.C., Mourah S., Podgorniak M.P., Seignerin J.M., Takada K., Joab I. Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J. Virol. 2006, 80:845-853.
2. Bittner J.J. The milk-influence of breast tumors in mice. Science 1942, 95:462-463.
3. Bloom H.J., Richardson W.W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 1957, 11:359-377.
4. Bonnet M., Guinebretiere J.M., Kremmer E., Grunewald V., Benhamou E., Contesso G., Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 1999, 91:1376-1381.
5. Brink A.A., van Den Brule A.J., van Diest P., Meijer C.J. Re: detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 2000, 92:655-656.
6. Chu P.G., Chang K.L., Chen Y.Y., Chen W.G., Weiss L.M. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am. J. Pathol. 2001, 159:571-578.
7. Chu J.S., Chen C.C., Chang K.J. In situ detection of Epstein-Barr virus in breast cancer. Cancer Lett. 1998, 124:53-57.
8. Dadmanesh F., Peterse J.L., Sapino A., Fonelli A., Eusebi V. Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein-Barr virus infection. Histopathology 2001, 38:54-61.
9. Deshpande C.G., Badve S., Kidwai N., Longnecker R. Lack of expression of the Epstein-Barr virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab. Invest. 2002, 82:1193-1199.
10. J. Ferlay, F. Bray, P. Pisani, D.M. Parkin, GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No. 5, Version 2.0, IARC Press, Lyon, 2004.
11. Fina F., Romain S., Ouafik L., Palmari J., Ben Ayed F., Benharkat S., Bonnier P., Spyratos F., Foekens J.A., Rose C., Buisson M., Gerard H., Reymond M.O., Seigneurin J.M., Martin P.M. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br. J. Cancer 2001, 84:783-790.
12. Gaffey M.J., Frierson H.F., Mills S.E., Boyd J.C., Zarbo R.J., Simpson J.F., Gross L.K., Weiss L.M. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod. Pathol. 1993, 6:721-728.
13. Ganem D. KSHV and Kaposi's sarcoma: the end of the beginning?. Cell 1997, 91:157-160.
14. Glaser S.L., Lin R.J., Stewart S.L., Ambinder R.F., Jarrett R.F., Brousset P., Pallesen G., Gulley M.L., Khan G., O'Grady J., Hummel M., Preciado M.V., Knecht H., Chan J.K., Claviez A. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int. J. Cancer 1997, 70:375-382.
15. Gopal M.R., Thomson B.J., Fox J., Tedder R.S., Honess R.W. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet 1990, 335:1598-1599.
16. Grinstein S., Preciado M.V., Gattuso P., Chabay P.A., Warren W.H., De Matteo E., Gould V.E. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res. 2002, 62:4876-4878.
17. Hachana M., Trimeche M., Ziadi S., Amara K., Gaddas N., Mokni M., Korbi S. Prevalence and characteristics of the MMTV-like associated breast carcinomas in Tunisia. Cancer Lett. 2008, 271:222-230.
18. Hachana M., Trimeche M., Ziadi S., Amara K., Korbi S. Evidence for a role of the Simian Virus 40 in human breast carcinomas. Breast Cancer Res. Treat. 2009, 113:43-58.
19. Kieff E., Rickinson A.B. Epstein-Barr virus. Fields Virology 2001, vol. 2:2511-2573. Lippincott Williams & Wilkins, Philadelphia.
20. Kijima Y., Hokita S., Takao S., Baba M., Natsugoe S., Yoshinaka H., Aridome K., Otsuji T., Itoh T., Tokunaga M., Eizuru Y., Aikou T. Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J. Med. Virol. 2001, 64:513-518.
21. Labrecque L.G., Barnes D.M., Fentiman I.S., Griffin B.E. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 1995, 55:39-45.
22. Lespagnard L., Cochaux P., Larsimont D., Degeyter M., Velu T., Heimann R. Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am. J. Clin. Pathol. 1995, 103:449-452.
23. Lin J.H., Tsai C.H., Chu J.S., Chen J.Y., Takada K., Shew J.Y. Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells. J. Virol. 2007, 81:5705-5713.
24. Macsween K.F., Crawford D.H. Epstein-Barr virus-recent advances. Lancet Infect. Dis. 2003, 3:131-140.
25. Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 2003, 22:5131-5140.
26. McCall S.A., Lichy J.H., Bijwaard K.E., Aguilera N.S., Chu W.S., Taubenberger J.K. Epstein-Barr virus detection in ductal carcinoma of the breast. J. Natl. Cancer Inst. 2001, 93:148-150.
27. Perkins R.S., Sahm K., Marando C., Dickson-Witmer D., Pahnke G.R., Mitchell M., Petrelli N.J., Berkowitz I.M., Soteropoulos P., Aris V.M., Dunn S.P., Krueger L.J. Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Res. 2006, 8:R70.
28. Preciado M.V., Chabay P.A., De Matteo E.N., Gonzalez P., Grinstein S., Actis A., Gass H.D. Epstein-Barr virus in breast carcinoma in Argentina. Arch. Pathol. Lab. Med. 2005, 129:377-381.
29. Preciado M.V. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma-another point of view. Breast Cancer Res. 2003, 5:E6.
30. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields Virology 1996, vol. 2:2397-2446. Lippincott-Raven, Philadelphia.
31. Ries L.A.G., Eisner M.P., Kosary C.L. SEER Cancer Statistics Review, 1973-1999 2002, National Cancer Institute, Bethesda, MD.
32. Sabin L., Wittekind C. TNM Classification of Malignant Tumours 1998, John Wiley & Sons Inc. 5th ed.
33. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., Erlich H.A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986, 324:163-166.
34. Serraino D., Piselli P., Scognamiglio P. Viral infections and cancer: epidemiological aspects. J. Biol. Regul. Homeost. Agents 2001, 15:224-228.
35. WHO, World Health Organization International of Diseases for Oncology 1990, World Health Organization, Geneva. 2nd ed.
36. Xue S.A., Lampert I.A., Haldane J.S., Bridger J.E., Griffin B.E. Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger?. Br. J. Cancer 2003, 89:113-119.
37. Yost K., Perkins C., Cohen R., Morris C., Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001, 12:703-711.
38. Yu D., Liu B., Jing T., Sun D., Price J.E., Singletary S.E., Ibrahim N., Hortobagyi G.N., Hung M.C. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol. Oncogene 1998, 16:2087-2094.
39. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 2000, 92:690-698.